[Myelobromel in the treatment of patients with idiopathic myelofibrosis during erythremic phase].
D002066:Busulfan / Q000627:therapeutic use; D002241:Carbohydrates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D011086:Polycythemia / Q000150:complications*; D055728:Primary Myelofibrosis / Q000150:complications / Q000188:drug therapy*
D002241:Carbohydrates; D002066:Busulfan
Lechenie mielobromolom bol'nykh idiopaticheskim mielofibrozom v éritremicheskoĭ faze.